• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星的抗菌活性及其作用方式。 (注:原文中多了一个of,正确表述应该是Antibacterial activity of ofloxacin and its mode of action. )

Antibacterial activity of ofloxacin and its mode of action.

作者信息

Sato K, Inoue Y, Fujii T, Aoyama H, Mitsuhashi S

出版信息

Infection. 1986;14 Suppl 4:S226-30. doi: 10.1007/BF01661277.

DOI:10.1007/BF01661277
PMID:3028966
Abstract

The antibacterial activity of ofloxacin against Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae was comparable to norfloxacin and enoxacin, and far exceeded the activity of pipemidic acid and nalidixic acid. The activity of ofloxacin was two to eight times less than that of ciprofloxacin. Ofloxacin was more active against Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Acinetobacter spp., Legionella spp., and Bacteroides fragilis, than norfloxacin, enoxacin, pipemidic acid and nalidixic acid, and the activity of ofloxacin was comparable to that of ciprofloxacin. Ofloxacin was two to seven times more effective than norfloxacin in systemic infections in mice with S. aureus, Escherichia coli, Serratia marcescens and P. aeruginosa. Ofloxacin strongly inhibited DNA supercoiling activity of DNA gyrase purified from E. coli KL-16. There is a parallel relationship between antibacterial activity of ofloxacin and its inhibitory action against DNA gyrases from ofloxacin-susceptible and ofloxacin-resistant clinical isolates of E. coli. These results indicate that the high bactericidal action of ofloxacin and the related new quinolone agents can be explained by their potent inhibitory activities against DNA gyrase in bacterial cells.

摘要

氧氟沙星对肠杆菌科细菌、铜绿假单胞菌、流感嗜血杆菌、卡他布兰汉菌和淋病奈瑟菌的抗菌活性与诺氟沙星和依诺沙星相当,且远远超过吡哌酸和萘啶酸的活性。氧氟沙星的活性比环丙沙星低2至8倍。与诺氟沙星、依诺沙星、吡哌酸和萘啶酸相比,氧氟沙星对金黄色葡萄球菌、表皮葡萄球菌、肺炎链球菌、不动杆菌属、军团菌属和脆弱拟杆菌更具活性,且氧氟沙星的活性与环丙沙星相当。在患有金黄色葡萄球菌、大肠杆菌、粘质沙雷氏菌和铜绿假单胞菌的小鼠全身性感染中,氧氟沙星的疗效比诺氟沙星高2至7倍。氧氟沙星强烈抑制从大肠杆菌KL-16纯化的DNA旋转酶的DNA超螺旋活性。氧氟沙星的抗菌活性与其对氧氟沙星敏感和耐药的大肠杆菌临床分离株的DNA旋转酶的抑制作用之间存在平行关系。这些结果表明,氧氟沙星及相关新喹诺酮类药物的高杀菌作用可通过它们对细菌细胞中DNA旋转酶的有效抑制活性来解释。

相似文献

1
Antibacterial activity of ofloxacin and its mode of action.氧氟沙星的抗菌活性及其作用方式。 (注:原文中多了一个of,正确表述应该是Antibacterial activity of ofloxacin and its mode of action. )
Infection. 1986;14 Suppl 4:S226-30. doi: 10.1007/BF01661277.
2
In vitro and in vivo activity of DL-8280, a new oxazine derivative.新型恶嗪衍生物DL-8280的体外和体内活性
Antimicrob Agents Chemother. 1982 Oct;22(4):548-53. doi: 10.1128/AAC.22.4.548.
3
In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.喹诺酮羧酸类药物氧氟沙星与其他喹诺酮类药物及其他抗菌药物的体外活性比较。
J Antimicrob Chemother. 1985 Nov;16(5):563-74. doi: 10.1093/jac/16.5.563.
4
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.培氟沙星、氧氟沙星、依诺沙星和环丙沙星对256株临床分离株的体外活性比较
Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):141-6. doi: 10.1111/j.1699-0463.1987.tb03102.x.
5
In-vitro activity of newer quinolones against aerobic bacteria.新型喹诺酮类药物对需氧菌的体外活性
J Antimicrob Chemother. 1986 Apr;17 Suppl B:29-39. doi: 10.1093/jac/17.suppl_b.29.
6
In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.新型6-氟-8-甲氧基喹诺酮类药物AM-1155的体外和体内抗菌活性
Antimicrob Agents Chemother. 1992 Oct;36(10):2108-17. doi: 10.1128/AAC.36.10.2108.
7
Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.三种新型喹诺酮类抗生素对近期临床分离株的体外活性比较
Scand J Infect Dis. 1985;17(1):91-4. doi: 10.3109/00365548509070426.
8
[Susceptibilities of clinical isolates to antibacterial agents. Focusing mainly on ofloxacin (first report). Reported by the Research Group for Testing Ofloxacin Susceptibility of Clinical Isolates].临床分离株对抗菌药物的敏感性。主要聚焦于氧氟沙星(首次报告)。临床分离株氧氟沙星敏感性检测研究组报告
Jpn J Antibiot. 1988 Jan;41(1):71-104.
9
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.新型喹诺酮衍生物T-3761的体外和体内抗菌活性
Antimicrob Agents Chemother. 1993 Mar;37(3):384-92. doi: 10.1128/AAC.37.3.384.
10
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.新型喹诺酮衍生物AM-833的体外和体内抗菌活性
Antimicrob Agents Chemother. 1986 Jun;29(6):1059-66. doi: 10.1128/AAC.29.6.1059.

引用本文的文献

1
Validation of a Standard Luminescence Method for the Fast Determination of the Antimicrobial Activity of Nanoparticles in .用于快速测定纳米颗粒抗菌活性的标准发光方法的验证 。 (原文结尾处“in.”后面似乎缺少内容)
Nanomaterials (Basel). 2022 Jun 23;12(13):2164. doi: 10.3390/nano12132164.
2
Rabies Vaccine Characterization by Nanoparticle Tracking Analysis.纳米颗粒跟踪分析对狂犬病疫苗的特征分析。
Sci Rep. 2020 May 18;10(1):8149. doi: 10.1038/s41598-020-64572-6.
3
The Polycyclic Polyprenylated Acylphloroglucinol Antibiotic PPAP 23 Targets the Membrane and Iron Metabolism in .

本文引用的文献

1
A simplified method of evaluating dose-effect experiments.一种评估剂量效应实验的简化方法。
J Pharmacol Exp Ther. 1949 Jun;96(2):99-113.
2
In vitro and in vivo activity of DL-8280, a new oxazine derivative.新型恶嗪衍生物DL-8280的体外和体内活性
Antimicrob Agents Chemother. 1982 Oct;22(4):548-53. doi: 10.1128/AAC.22.4.548.
3
In vitro antibacterial activity of AM-715, a new nalidixic acid analog.新型萘啶酸类似物AM - 715的体外抗菌活性
多环多异戊二烯基化酰基间苯三酚抗生素PPAP 23作用于……的膜和铁代谢
Front Microbiol. 2019 Jan 22;10:14. doi: 10.3389/fmicb.2019.00014. eCollection 2019.
4
Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity.持留菌-FACSeq的开发:一种大规模并行量化持留菌生理学及其异质性的方法。
Sci Rep. 2016 May 4;6:25100. doi: 10.1038/srep25100.
5
Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.对氧氟沙星的稳定期持续存活菌会持续存在DNA损伤,并且仅在恢复过程中需要修复系统。
mBio. 2015 Sep 1;6(5):e00731-15. doi: 10.1128/mBio.00731-15.
6
Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes.兔眼玻璃体内注射脂质体包裹型和游离型氧氟沙星后的视网膜毒性
Int Ophthalmol. 1998;22(3):133-43. doi: 10.1023/a:1006137100444.
7
Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.喹诺酮类药物对大肠杆菌拓扑异构酶IV的抑制作用与对DNA旋转酶抑制作用的比较。
Antimicrob Agents Chemother. 1994 Nov;38(11):2623-7. doi: 10.1128/AAC.38.11.2623.
8
Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.喹诺酮类药物对大肠杆菌DNA回旋酶及胎牛胸腺拓扑异构酶II的抑制作用。
Antimicrob Agents Chemother. 1989 Oct;33(10):1816-8. doi: 10.1128/AAC.33.10.1816.
9
Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms.氧氟沙星、庆大霉素和妥布霉素在泪液中的浓度与90%受试微生物体外最低抑菌浓度的比较。 (注:原文中多了一个of,正确句子应该是Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms. )
Antimicrob Agents Chemother. 1990 Aug;34(8):1602-4. doi: 10.1128/AAC.34.8.1602.
10
Ofloxacin compared with chloramphenicol in the management of external ocular infection.氧氟沙星与氯霉素在外眼感染治疗中的比较。
Br J Ophthalmol. 1991 Nov;75(11):675-9. doi: 10.1136/bjo.75.11.675.
Antimicrob Agents Chemother. 1980 Feb;17(2):103-8. doi: 10.1128/AAC.17.2.103.
4
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.与脱氧核糖核酸回旋酶活性相关的新的萘啶酸抗性突变
J Bacteriol. 1981 Nov;148(2):450-8. doi: 10.1128/jb.148.2.450-458.1981.
5
DNA gyrase: affinity chromatography on novobiocin-Sepharose and catalytic properties.DNA 回旋酶:新生霉素 - 琼脂糖亲和层析及催化特性
Nucleic Acids Res. 1981 Aug 11;9(15):3589-603. doi: 10.1093/nar/9.15.3589.
6
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.环丙沙星(拜奥9867)、诺氟沙星、吡哌酸和萘啶酸的比较活性。
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4. doi: 10.1128/AAC.24.2.302.
7
In vitro and in vivo antibacterial activity of AT-2266.AT-2266的体外和体内抗菌活性
Antimicrob Agents Chemother. 1983 Jul;24(1):78-84. doi: 10.1128/AAC.24.1.78.
8
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.耐萘啶酸的大肠杆菌K-12突变体:基因定位与显性研究。
J Bacteriol. 1969 Jul;99(1):238-41. doi: 10.1128/jb.99.1.238-241.1969.
9
Replication of colicin E1 plasmid DNA in cell extracts.大肠杆菌素E1质粒DNA在细胞提取物中的复制
Proc Natl Acad Sci U S A. 1974 Mar;71(3):802-6. doi: 10.1073/pnas.71.3.802.
10
Involvement of DNA gyrase in bacteriophage T7 DNA replication.DNA 回旋酶参与噬菌体 T7 DNA 的复制。
Nature. 1977 Nov 3;270(5632):78-80. doi: 10.1038/270078a0.